Politico September 18, 2024
By Ben Leonard and Chelsea Cirruzzo

With Lauren Gardner and Daniel Payne

Driving the Day

READING THE PHARMA TEA LEAVES — Democratic presidential candidate Kamala Harris is launching several health care events with providers, advocates and lawmakers in swing states this week, signaling the issue will continue to be a major part of her campaign.

As California attorney general, Harris focused on health care — including challenging drug patent holders and unfair practices in marketing treatments for off-label use.

She’s now leaning into speeding up government drug pricing negotiations to reduce costs to Medicare beneficiaries and has previously supported “march-in” rights, when the government can lower prices by awarding a patent for research it funded to another company. Such measures signal an aggressive stance on drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Inflation Reduction Act: A Battleground for Health Care Policy
Protecting Patients from Deceptive Drug Ads Online Act Introduced
There are more than 120 AI bills in Congress right now
White House unveils sweeping healthcare safety efforts: 8 notes
ACA in The Presidential Debate

Share This Article